
By Dividendinvestr : By Kersasp Shekhdar The company behind that instantly-recognizable chocolate, Toblerone, Kraft Foods Inc. ( KFT ) occupies a lonely position in the United States - competitors are few and far between. Kraft competes with Sara Lee in packaged meats and frozen desserts and with
By Muhammad Bazil : Abbott ( ABT ) is one of the movers and shakers in America's mainstream drug manufacturing industry. Nested on a market cap of $97 billion, it is submerged in highly competitive waters. It has to compete with aggressive competitors like Pfizer ( PFE ) and Merck ( MRK ) . The ...
By Stock Croc : Coca-Cola ( KO ) is the largest soft drink company in the world. Coca-Cola is also an international company that has one of the best known brand names in the world. "The company generates 70% of its revenue and about 80% of its operating profit from outside the United States." The
By Guraaf : I am a small individual investor interested in dividend growth stocks and foreign equities. Most of my current holdings are U.S. companies but over the last couple of years, I have diversified into foreign stocks as well. I want to share some of the lessons that I learned about ...
By Guraaf : In Part 1 of my Primer on International Investing, I discussed the benefits and risks involved in investing in foreign companies. I am an individual retail investor. I educated myself about foreign stocks by reading online and sometimes the hard way by first investing in a foreign stock
By Vatalyst : The history of Valeant Pharmaceuticals ( VRX ) is one of constant change. The company's oldest root seems to be ICN Pharmaceuticals, founded in the 1950s by Milan Panic, an amazing man who managed to serve as Prime Minister of Yugoslavia in 1992-1993 while still an American citizen.
eclectic portfolio, but no single name dominates. Other top holdings include Comcast CMCSA, U.S. Bancorp USB, and Nestle NSRGY . Morningstar associate director of fund analysis Shannon Zimmerman says managers Richard Witmer, Tim Hartch, and Michael
By Analytical Chemist : With Pfizer's ( PFE ) continued retreat from the research and development that made it the world's largest pharmaceutical company, I recently sold my position in Pfizer. As it cuts costs by reducing research and development expenses, management clearly places a premium on ...
Benzinga : By Ilir Shkurti Pfizer's ( PFE ) announcement that it has an agreement to sell its Nutrition business to Nestlé ( NSRGY .PK ) for $11.85 billion in cash has given rise to expectations share valuation catalysts through share repurchasing as
By Cris Frangold : Johnson & Johnson ( JNJ ) has released its results for the first quarter of 2012 and its earnings-per-share of $1.37 was just above the consensus estimate of $1.35. Revenues for the quarter at $16.1 billion were marginally lower than the expectations of $16.26 billion. Revenues